Regent Pacific Group Ltd. Registered Shares DL -,01
- BID
0.105
- ASK
0.117
- 19,048 Units17,094 Units
- 07/21, 21:57:10 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
7.10%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.02 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.105 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:57:10 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.105 | 0.091 |
| PREV. DAY'S PRICE | 0.098 | (07/20) |
| CHANGE DAY BEFORE | +0.01 | 7.14 % |
| 52 WEEK HIGH / LOW | 0.121 (12/09) | 0.058 (06/16) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.10 | -0.02 | -0.02 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | - | - | - | - | - |
PRICE - SALES RATIO | 39.01 | 16.29 | 103.11 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A3ESSZ |
| ISIN | KYG3042R1314 |
| SYMBOL | RPG |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | REGENT PACIFIC |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.03 % | -4.85 % | 36.11 % | -3.92 % | 7.10 % | 55.56 % | -69.18 % | 2.08 % |
| HIGH | 0.10 | 0.12 | 0.12 | 0.12 | 0.12 | 0.14 | 1.60 | 0.12 |
| LOW | 0.09 | 0.09 | 0.06 | 0.06 | 0.06 | 0.02 | 0.02 | 0.06 |
Dividende
pro Aktie
REGENT PACIFIC does not deliver dividend information
Company profile
Regent Pacific Group Ltd. is an investment holding company, which engages in investments in biopharma companies, resources, and other corporate investments. It operates through Biopharma and Corporate Investment segments. The Biopharma manages research, development, manufacturing, marketing, and sales of pharmaceutical products. The Corporate Investment segment offers investment in corporate entities, both listed and unlisted. The company was founded by James Mellon and Jayne Allison Sutcliffe in 1990 and is headquartered in Hong Kong.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.